yingweiwo

T-2513 hydrochloride

Alias: T-2513 hydrochloride
Cat No.:V35271 Purity: ≥98%
T-2513 hydrochloride is a potent topoisomerase I inhibitor.
T-2513 hydrochloride
T-2513 hydrochloride Chemical Structure CAS No.: 187793-52-8
Product category: DNA(RNA) Synthesis
This product is for research use only, not for human use. We do not sell to patients.
Size Price
500mg
1g
Other Sizes

Other Forms of T-2513 hydrochloride:

  • T-2513
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
T-2513 hydrochloride is a potent topoisomerase I inhibitor. T-2513 hydrochloride inhibits DNA replication and RNA synthesis, stabilizes the topoisomerase I-DNA complex through covalent binding, and ultimately causes cell death.
T-2513 hydrochloride (CAS#: 187793-52-8) is a selective inhibitor of topoisomerase I with the molecular formula C25H28ClN3O5 and a molecular weight of 485.96 g/mol. It is a camptothecin-derived small molecule that acts as a covalent stabilizer of the topoisomerase I-DNA complex. By binding to and stabilizing this complex, T-2513 hydrochloride inhibits DNA replication and RNA synthesis, ultimately leading to cell death. It is a valuable research tool for studying topoisomerase I biology and for developing anticancer therapies.
Biological Activity I Assay Protocols (From Reference)
Targets
Topoisomerase I
The primary biological target of T-2513 hydrochloride is topoisomerase I, an enzyme that relieves torsional stress in DNA during replication and transcription by creating transient single-strand breaks. T-2513 hydrochloride binds covalently to the topoisomerase I-DNA complex and stabilizes it, preventing the religation of the DNA strand. This leads to the accumulation of DNA breaks, which block DNA replication and RNA synthesis, ultimately causing cell death. This mechanism of action is shared with other camptothecin derivatives, such as irinotecan and topotecan.
ln Vitro
SN-38 is T-2513 hydrochloride's metabolite[1]. The cytotoxicity of T-2513 hydrochloride against various human tumor cell lines is broad[2].
In vitro, T-2513 hydrochloride is a selective inhibitor of topoisomerase I. It covalently binds to and stabilizes the topoisomerase I-DNA complex, inhibiting DNA replication and RNA synthesis, ultimately leading to cell death. The compound's antiproliferative activity against cancer cell lines is assessed using standard cell viability assays. The inhibition of topoisomerase I is confirmed by measuring the stabilization of the enzyme-DNA complex using a DNA relaxation assay.
ln Vivo
T-2513 hydrochloride (1-100 mg/kg) indicates Walker-256 cancer Antitumor Activity[2].
Information regarding the in vivo activity of T-2513 hydrochloride in animal models is limited. Its biological activity has been characterized primarily through in vitro assays. The compound's potent in vitro activity and its mechanism of action suggest it may have in vivo efficacy, but this has not been extensively studied. Further studies are required to determine its pharmacokinetic properties, bioavailability, and efficacy in animal models of cancer.
Enzyme Assay
The non-cellular enzyme or receptor binding assay for T-2513 hydrochloride involves measuring its inhibition of topoisomerase I activity. This is typically performed using a DNA relaxation assay with purified topoisomerase I enzyme and supercoiled DNA. The conversion of supercoiled DNA to relaxed DNA is assessed by gel electrophoresis. In the presence of the inhibitor, the rate of relaxation is reduced. The compound's ability to stabilize the enzyme-DNA complex is assessed by measuring the persistence of the cleaved complex.
Cell Assay
Cell Viability Assay[2]
Cell Types: WiDr, HT-29, SK-BR-3, MKN-1, SK-LU-1, LX-1, KB, and HeLaS3 cells
Tested Concentrations: 15.1-111.5 ng/mL
Incubation Duration: 24 hrs (hours)
Experimental Results: demonstrated cytotoxicity against a panel of human tumor cell lines with GI50s of 32.1, 97.6, 38.6, 15.6, 111.5, 15.1, 34.0, and 50.9 ng/mL for WiDr, HT -29, SK-BR-3, MKN-1, SK-LU-1, LX-1, KB, and HeLaS3 cells, respectively.
The in vitro cellular assay for T-2513 hydrochloride involves treating cancer cell lines with various concentrations of the compound. Cell viability is assessed using standard assays such as MTT or SRB to determine the IC50. The induction of DNA damage is assessed by measuring the phosphorylation of histone H2AX (γ-H2AX) using immunofluorescence or western blotting. Apoptosis is evaluated using flow cytometry with Annexin V/PI staining or by measuring caspase-3/7 activity.
Animal Protocol
Animal/Disease Models: Rats bearing Walker-256 carcinoma [2]
Doses: 1, 10, and 100 mg/kg
Route of Administration:
Experimental Results: The ED50 was 23 mg/kg.
The in vivo animal experiment workflow for T-2513 hydrochloride has not been well-established. If an animal study were to be designed, a xenograft model using a cancer cell line in immunodeficient mice would be appropriate. The compound would be administered at various doses and routes. Tumor growth would be monitored by measuring tumor volume. At the end of the study, tumors would be excised and analyzed for markers of topoisomerase I inhibition and apoptosis.
References
[1]. Stephan A Veltkamp, et al. Clinical and pharmacologic study of the novel prodrug delimotecan (MEN 4901/T-0128) in patients with solid tumors. Clin Cancer Res. 2008 Nov 15;14(22):7535-44.
[2]. S Okuno, et al. Complete regression of xenografted human carcinomas by camptothecin analogue-carboxymethyl dextran conjugate (T-0128). Cancer Res. 2000 Jun 1;60(11):2988-95.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C25H28CLN3O5
Molecular Weight
485.95992565155
Exact Mass
485.17
CAS #
187793-52-8
Related CAS #
T-2513;288247-87-0
PubChem CID
9848247
Appearance
Typically exists as solid at room temperature
tPSA
115
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
7
Rotatable Bond Count
6
Heavy Atom Count
34
Complexity
885
Defined Atom Stereocenter Count
1
SMILES
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OCCCN.Cl
InChi Key
MIZGPLODSZKVPX-UQIIZPHYSA-N
InChi Code
InChI=1S/C25H27N3O5.ClH/c1-3-15-16-10-14(32-9-5-8-26)6-7-20(16)27-22-17(15)12-28-21(22)11-19-18(23(28)29)13-33-24(30)25(19,31)4-2;/h6-7,10-11,31H,3-5,8-9,12-13,26H2,1-2H3;1H/t25-;/m0./s1
Chemical Name
(19S)-7-(3-aminopropoxy)-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;hydrochloride
Synonyms
T-2513 hydrochloride
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0578 mL 10.2889 mL 20.5778 mL
5 mM 0.4116 mL 2.0578 mL 4.1156 mL
10 mM 0.2058 mL 1.0289 mL 2.0578 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • Plasma concentration versus time curves for total T-2513 (A), free T-2513 (B), SN-38 (C), SN-38G (D), and T-1335 (E). Clin Cancer Res . 2008 Nov 15;14(22):7535-44.
  • AUC per dose level for total T-2513 (A), SN-38 (B), SN-38G (C), and T-1335 (D). Clin Cancer Res . 2008 Nov 15;14(22):7535-44.
Contact Us